Alterome Therapeutics
private
Alterome Therapeutics is dedicated to advancing precision oncology through the creation of alteration-specific medicines. The company is leveraging a novel computational chemistry platform to target validated, high-value oncogenic drivers using small molecule inhibitors. Considered the gold standard approach in oncology, its targeted therapies home in on molecular characteristics unique to tumor drivers, which are absent from healthy cells, thereby limiting treatment-related toxicities and improving the therapeutic index for patients.